Literature DB >> 6818152

The effect of short-term cefoxitin prophylaxis on the colonic microflora in patients undergoing colorectal surgery.

L Kager, A S Malmborg, C E Nord, R Pieper.   

Abstract

Cefoxitin was administered intravenously to 11 patients undergoing colorectal surgery; the initial dose was 2 g given at the induction of anesthesia followed by two 2 g doses at intervals of six hours. Serum samples and faecal specimens were taken to determine the cefoxitin concentrations. Tissue samples from the gut wall were obtained at surgery. The serum concentrations 15 min after administration ranged from 106.6 to 664.0 mg/l [mean: 295.8 +/- 61.0 (SE) mg/l]. Cefoxitin concentrations in the faecal samples were between 0 and 57.7 mg/kg. Cefoxitin concentrations in the tissue samples varied from 9.0 to 68.3 mg/kg. Faecal samples were also obtained during the investigation period for the cultivation of aerobic and anaerobic bacteria. Enterobacteria decreased and enterococci increased during the first two days. Anaerobic cocci and gram-negative rods also decreased during the same period. The colonic microflora returned to normal after two weeks in all patients and no new colonizing cefoxitin-resistant bacteria were isolated. No postoperative infections occurred.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818152     DOI: 10.1007/bf01642294

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  6 in total

1.  WOUND SEPSIS AFTER CLEAN OPERATIONS.

Authors:  U LJUNGQVIST
Journal:  Lancet       Date:  1964-05-16       Impact factor: 79.321

Review 2.  Use of prophylactic antibiotics in surgical practice.

Authors:  R L Nichols
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

3.  Antimicrobial prophylaxis to prevent mixed bacterial infection.

Authors:  B F Polk
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

4.  Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies.

Authors:  H Wallick; D Hendlin
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

5.  A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis.

Authors:  F P Tally; K McGowan; J M Kellum; S L Gorbach; T F O'Donnell
Journal:  Ann Surg       Date:  1981-03       Impact factor: 12.969

6.  Antibiotic prophylaxis with cefoxitin in colorectal surgery: effect on the colon microflora and septic complications--a clinical model for prediction of the benefit and risks in using a new antibiotic in prophylaxis.

Authors:  L Kager; I Ljungdahl; A S Malmborg; C E Nord; R Pieper; P Dahlgren
Journal:  Ann Surg       Date:  1981-03       Impact factor: 12.969

  6 in total
  5 in total

Review 1.  The Biology of Anastomotic Healing-the Unknown Overwhelms the Known.

Authors:  Adam Lam; Brian Fleischer; John Alverdy
Journal:  J Gastrointest Surg       Date:  2020-06-10       Impact factor: 3.452

Review 2.  The intestinal microbiome and surgical disease.

Authors:  Monika A Krezalek; Kinga B Skowron; Kristina L Guyton; Baddr Shakhsheer; Sanjiv Hyoju; John C Alverdy
Journal:  Curr Probl Surg       Date:  2016-06-14       Impact factor: 1.909

3.  Collagen degradation and MMP9 activation by Enterococcus faecalis contribute to intestinal anastomotic leak.

Authors:  Benjamin D Shogan; Natalia Belogortseva; Preston M Luong; Alexander Zaborin; Simon Lax; Cindy Bethel; Marc Ward; Joseph P Muldoon; Mark Singer; Gary An; Konstantin Umanskiy; Vani Konda; Baddr Shakhsheer; James Luo; Robin Klabbers; Lynn E Hancock; Jack Gilbert; Olga Zaborina; John C Alverdy
Journal:  Sci Transl Med       Date:  2015-05-06       Impact factor: 17.956

4.  Identification and characterization of potential therapeutic candidates in emerging human pathogen Mycobacterium abscessus: a novel hierarchical in silico approach.

Authors:  Buvaneswari Shanmugham; Archana Pan
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

5.  Effects of treatment with antimicrobial agents on the human colonic microflora.

Authors:  Fatemeh Rafii; John B Sutherland; Carl E Cerniglia
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.